ZYME
ZYME
NASDAQ · Biotechnology

Zymeworks Inc

$26.61
-0.93 (-3.38%)
As of May 9, 1:32 AM ET ·
Financial Highlights (FY 2026)
Revenue
91.55M
Net Income
-70,089,188
Gross Margin
Profit Margin
-76.6%
Rev Growth
-36.4%
D/E Ratio
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 42.5% 42.5%
Operating Margin -87.3% -78.6% 19.5% 17.9%
Profit Margin -76.6% -72.7% 15.6% 18.1%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 91.55M 144.01M 182.20M 158.08M
Gross Profit 77.45M 67.20M
Operating Income -79,957,894 -113,201,360 35.58M 28.36M
Net Income -70,089,188 -99,229,619 28.41M 28.63M
Gross Margin 42.5% 42.5%
Operating Margin -87.3% -78.6% 19.5% 17.9%
Profit Margin -76.6% -72.7% 15.6% 18.1%
Rev Growth -36.4% -36.4% +8.1% +23.2%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 0 595.07M 530.52M
Total Equity 1.01B 987.85M
D/E Ratio 0.59 0.54
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -76,740,462 -114,682,143 52.86M 47.86M
Free Cash Flow 21.80M 16.91M